SCMP

1 stories · following the connections

Business

Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with Priority Review Designation

By Nasdaq OMXSep 28, 2017, 9:34 PM UTC